Compare WHR & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WHR | ALKS |
|---|---|---|
| Founded | 1911 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.5B |
| IPO Year | 1994 | 2012 |
| Metric | WHR | ALKS |
|---|---|---|
| Price | $58.81 | $28.05 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 14 |
| Target Price | ★ $84.43 | $43.43 |
| AVG Volume (30 Days) | ★ 2.9M | 1.7M |
| Earning Date | 04-29-2026 | 05-22-2026 |
| Dividend Yield | ★ 6.13% | N/A |
| EPS Growth | ★ 196.42 | N/A |
| EPS | ★ 5.66 | 1.43 |
| Revenue | ★ $21,253,000,000.00 | $1,475,899,000.00 |
| Revenue This Year | $0.07 | $24.06 |
| Revenue Next Year | $3.57 | $4.53 |
| P/E Ratio | ★ $10.45 | $20.01 |
| Revenue Growth | ★ 2.58 | N/A |
| 52 Week Low | $58.65 | $25.17 |
| 52 Week High | $111.96 | $36.32 |
| Indicator | WHR | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 22.55 | 30.68 |
| Support Level | N/A | $27.77 |
| Resistance Level | $80.65 | $28.75 |
| Average True Range (ATR) | 2.94 | 1.04 |
| MACD | -1.91 | -0.44 |
| Stochastic Oscillator | 6.90 | 11.46 |
Whirlpool Corp is a manufacturer and marketer of home appliances and related products. Its reportable segments consist of five operating segments, which consist of Domestic Appliances (MDA) North America; MDA Europe, MDA Latin America; MDA Asia; and Small Domestic Appliances (SDA). Product categories include refrigeration, laundry, cooking, and dishwashing. The company has also a portfolio of small domestic appliances, including the KitchenAid stand mixer. The company's international brands include Whirlpool, KitchenAid, Maytag, Consul, and Brastemp, among others.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.